Marksans Pharma Q1 Results
- BSE: 524404
- NSE: MARKSANS
- ISIN: INE750C01026
- Sector: Biotechnology & Drugs
BSE
167.20
-6.10 (-3.52%)
-6.10 (-3.52%)Volume48.02 K
Updated: Fri 13 Mar, 2026 | 15:42:58
NSE
166.72-6.46 (-3.73%)
-6.46 (-3.73%)Volume8.61 L
Updated: Fri 13 Mar, 2026 | 15:25:52
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Marksans Pharma Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 542.97 | 605.45 | -10.32% | 482.63 | 12.50% |
| Depreciation/ Amortization | 23.10 | 22.74 | 1.57% | 20.44 | 13.00% |
| Operating Income | 77.02 | 103.01 | -25.23% | 107.99 | -28.68% |
| Net Income | 58.32 | 90.54 | -35.59% | 88.75 | -34.29% |
| Other Operating Expenses Total | 159.67 | 160.27 | -0.37% | 119.92 | 33.15% |
| Net Income Before Taxes | 76.60 | 116.09 | -34.02% | 120.02 | -36.18% |
| Total Revenue | 619.99 | 708.46 | -12.49% | 590.62 | 4.97% |
| Selling/ General/ Admin Expenses Total | 98.39 | 97.22 | 1.20% | 80.48 | 22.24% |
| Diluted Normalized EPS | 1.29 | 2.00 | -35.44% | 1.96 | -34.18% |